Detalhe da pesquisa
1.
Upregulated expression and function of the α4ß1 integrin in multiple myeloma cells resistant to bortezomib.
J Pathol
; 252(1): 29-40, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32501543
2.
Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma.
Am J Hematol
; 94(8): 853-861, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31074033
3.
Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma.
Blood
; 128(18): 2241-2252, 2016 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27625360
4.
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.
Sci Transl Med
; 16(734): eadg7962, 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38354229
5.
Regulation of miRNA expression by α4ß1 integrin-dependent multiple myeloma cell adhesion.
EJHaem
; 4(3): 631-638, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37601846
6.
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1188818, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37342332
7.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1243241, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37662957
8.
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Front Immunol
; 14: 1349296, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38268917
9.
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.
Commun Biol
; 6(1): 1299, 2023 12 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38129580
10.
Overcoming tumor resistance mechanisms in CAR-NK cell therapy.
Front Immunol
; 13: 953849, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35990652
11.
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia.
J Clin Invest
; 132(15)2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35671096
12.
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma.
Blood Cancer J
; 11(8): 146, 2021 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34392311
13.
Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma.
Cancers (Basel)
; 13(7)2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33916196
14.
Rescue of pyruvate kinase deficiency in mice by gene therapy using the human isoenzyme.
Mol Ther
; 17(12): 2000-9, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19755962
15.
The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements.
PLoS One
; 15(8): e0237155, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32866200
16.
Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma.
Blood Adv
; 4(10): 2163-2171, 2020 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32433744
17.
In vitro sensitivity of granulo-monocytic progenitors as a new toxicological cell system and endpoint in the ACuteTox Project.
Toxicol Appl Pharmacol
; 238(2): 111-9, 2009 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19442680
18.
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
PLoS One
; 13(9): e0203392, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30192814
19.
Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells.
Clin Cancer Res
; 23(19): 5824-5835, 2017 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28659311
20.
Targeted gene therapy and cell reprogramming in Fanconi anemia.
EMBO Mol Med
; 6(6): 835-48, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24859981